LifeSteps Financial’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$208K Sell
1,517
-8
-0.5% -$1.13K 0.1% 107
2026
Q2
$224K Sell
1,525
-72
-5% -$13K 0.1% 93
2026
Q1
$235K Sell
1,597
-40
-2% -$6.5K 0.15% 84
2025
Q4
$319K Buy
1,637
+40
+3% +$9.5K 0.2% 71
2025
Q3
$449K Buy
1,597
+20
+1% +$5.09K 0.29% 54
2025
Q2
$345K Hold
1,577
– – 0.24% 65
2025
Q1
$221K Sell
1,577
-50
-3% -$8.14K 0.18% 78
2024
Q4
$271K Buy
+1,627
New +$289K 0.21% 71
2024
Q2
– Sell
-658
Closed -$82.7K – 305
2024
Q1
$82.7K Buy
+658
New +$75.3K 0.06% 118

Other funds holding ORCL

LifeSteps Financial's ORCL Position: Q3 2026 in Review

LifeSteps Financial reduced its Oracle (ORCL) stake by 0.52% in Q3 2026, selling an estimated $1.13K and leaving 1,517 shares worth $208K. The position accounts for 0.1% of the portfolio, ranked #107.

LifeSteps Financial first reported a position in ORCL in Q1 2024 and has held it in 9 quarters since. The position peaked at $449K in Q3 2025. 3,443 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.

  • LifeSteps Financial held 1,517 shares of Oracle worth $208K as of Q3 2026.
  • LifeSteps Financial sold 8 Oracle shares in Q3 2026, an estimated $1.13K.
  • Oracle made up 0.1% of LifeSteps Financial's portfolio in Q3 2026, its #107 holding.
  • LifeSteps Financial first reported a position in Oracle in Q1 2024 and has held it in 9 quarters since.
  • LifeSteps Financial's Oracle position peaked at $449K in Q3 2025.
  • 3,443 funds tracked by Wall St. Rank held Oracle as of Q3 2026.

Based on LifeSteps Financial's 13F filing for Q3 2026, filed 15 Oct 2026.